Sangui Biotech International Inc
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and woun… Read more
Sangui Biotech International Inc (SGBI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2024: -0.002x
Based on the latest financial reports, Sangui Biotech International Inc (SGBI) has a cash flow conversion efficiency ratio of -0.002x as of March 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.02K) by net assets ($-1.05 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sangui Biotech International Inc - Cash Flow Conversion Efficiency Trend (2000–2023)
This chart illustrates how Sangui Biotech International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sangui Biotech International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sangui Biotech International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BFNX39
SA:BFNX39
|
N/A |
|
Dong Won Fisheries Co. Ltd.
KQ:030720
|
N/A |
|
WLMM3F
SA:WLMM3F
|
N/A |
|
Canadian Life Companies Split Corp
PINK:CLSPF
|
0.221x |
|
MTR (MRI.SG)
STU:MRI
|
N/A |
|
SIBEK
ST:SIBEK
|
-0.039x |
|
Advantex Marketing International Inc
PINK:ATXMF
|
-0.038x |
|
AGRO3F
SA:AGRO3F
|
N/A |
Annual Cash Flow Conversion Efficiency for Sangui Biotech International Inc (2000–2023)
The table below shows the annual cash flow conversion efficiency of Sangui Biotech International Inc from 2000 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-06-30 | $-1.04 Million | $-11.64K | 0.011x | -92.85% |
| 2022-06-30 | $-894.96K | $-140.46K | 0.157x | -5.81% |
| 2021-06-30 | $-875.33K | $-145.85K | 0.167x | -27.78% |
| 2020-06-30 | $-729.88K | $-168.39K | 0.231x | -56.91% |
| 2019-06-30 | $-591.99K | $-316.92K | 0.535x | -25.92% |
| 2018-06-30 | $-351.14K | $-253.76K | 0.723x | -41.73% |
| 2017-06-30 | $-260.52K | $-323.10K | 1.240x | -22.22% |
| 2016-06-30 | $-247.57K | $-394.76K | 1.595x | -10.03% |
| 2015-06-30 | $-339.83K | $-602.29K | 1.772x | +101.70% |
| 2014-06-30 | $7.28K | $-760.23K | -104.485x | -3579.08% |
| 2013-06-30 | $296.34K | $-841.61K | -2.840x | -276.88% |
| 2012-06-30 | $959.37K | $-722.93K | -0.754x | -103.23% |
| 2011-06-30 | $-40.91K | $-955.21K | 23.351x | +793.67% |
| 2010-06-30 | $-301.00K | $-786.49K | 2.613x | 0.00% |
| 2009-06-30 | $-301.00K | $-786.49K | 2.613x | +146.95% |
| 2008-06-30 | $-1.08 Million | $-1.14 Million | 1.058x | +100.04% |
| 2007-06-30 | $162.00 | $-414.59K | -2559.216x | -347168.40% |
| 2006-06-30 | $-383.70K | $-282.94K | 0.737x | +126.05% |
| 2005-06-30 | $517.29K | $-1.46 Million | -2.831x | 0.00% |
| 2004-06-30 | $517.29K | $-1.46 Million | -2.831x | -195.63% |
| 2003-06-30 | $2.08 Million | $-2.00 Million | -0.958x | -37.86% |
| 2002-06-30 | $4.06 Million | $-2.82 Million | -0.695x | -129.25% |
| 2001-06-30 | $6.64 Million | $-2.01 Million | -0.303x | -152.05% |
| 2000-06-30 | $9.32 Million | $-1.12 Million | -0.120x | -- |